Significance of hemoglobin and hematocrit changes in predicting patient survival and efficacy of neoadjuvant chemotherapy for advanced gastric cancer

Table 2 Logistic multivariate analysis of factors associated with response to neoadjuvant chemotherapy for advanced gastric cancer

Factors	Beta	SE	Wald	OR	P value	95%CI
Tumor diameter > 5 cm	1.079	0.501	4.630	2.942	0.031	2.492-4.095
Lymph node metastasis	1.102	0.468	5.544	3.012	0.018	2.684-4.348
Chemotherapy cycles ≤ 3 cycles	0.577	0.204	7.996	1.782	0.004	3.283-4.174
Hematocrit < 33%	0.699	0.307	5.165	2.012	0.023	2.783-3.573
Hemoglobin < 107 g/L	0.833	0.379	4.814	2.301	0.028	2.485-4.128

OR: Odds ratio.